Find out how to get involved. Become a member, join our numerous sections, interest groups, working groups and task forces and get your research rolling, or deepen your education by visiting our Knowledge Hub.
Access educational modules, find all of our scientific resources, gain access to our journals and the newest research in this platform dedicated to science.
Network with peers and bounce off ideas for future research and collaborations. We have dedicated groups on every aspect of allergy, asthma and clinical immunology. Get in touch!
EAACI supports medical professionals from the beginning of their studies and throughout their professional careers. Here you can find a selection of job opportunities.
Our community constantly works towards improving patient lives. Find resources and information dedicated to allergy and asthma patients and their families and loved ones in this section.
Access educational modules, find all of our scientific resources, gain access to our journals and the newest research in this platform dedicated to science.
Initiation of dupilumab led to reduced use of corticosteroids and antibiotics over 12 months in patients with chronic rhinosinusitis with nasal polyps treated in US real world practice
Effectiveness and Safety of Dupilumab in patients with chronic rhinosinusitis with nasal polyps After One Year of Therapy: Results from a real-world non-interventional study in Germany (ProGNOSE)
Mepolizumab significantly reduces clinical interventions in the management of patients with CRSwNP: post hoc analysis of SYNAPSE using a composite endpoint
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
The effect of therapies targeting Type 2 inflammation on Neutrophil Extracellular Traps (NETs) and Extracellular Eosinophilic Traps (EETs) in severe CRSwNP